Fig. 4From: Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcomeAxial CT images at the level of L3 vertebra demonstrating progressive sarcopenia in a patient with oesophageal cancer before (a) and after (b) neoadjuvant chemotherapy. There is a loss of abdominal muscle mass with an increase in visceral fatBack to article page